PAG
NAGE

Private Advisor Group’s Niagen Bioscience NAGE Stock Holding History

Private Advisor Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,934
Closed -$120K – 1828
2020
Q3 		$120K Hold
29,934
– – ﹤0.01% 1474
2020
Q2 		$137K Hold
29,934
– – ﹤0.01% 1536
2020
Q1 		$98K Hold
29,934
– – ﹤0.01% 1331
2019
Q4 		$129K Hold
29,934
– – ﹤0.01% 1540
2019
Q3 		$118K Buy
29,934
+7,684
+35% +$32.8K ﹤0.01% 1570
2019
Q2 		$103K Hold
22,250
– – ﹤0.01% 1596
2019
Q1 		$93K Hold
22,250
– – ﹤0.01% 1494
2018
Q4 		$76K Sell
22,250
-50
-0.2% -$174 ﹤0.01% 1306
2018
Q3 		$96K Buy
+22,300
New +$95.9K ﹤0.01% 1541
2018
Q2 		– Sell
-20,750
Closed -$87K – 1467
2018
Q1 		$87K Buy
+20,750
New +$109K ﹤0.01% 1113

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Private Advisor Group's NAGE Position: Q4 2020 in Review

Private Advisor Group sold out of Niagen Bioscience (NAGE) in Q4 2020, closing a stake of 29,934 shares — an estimated $120K sold.

Private Advisor Group first reported a position in NAGE in Q1 2018 and held it in 10 quarters. The position peaked at $137K in Q2 2020. 83 funds tracked by Wall St. Rank hold NAGE as of Q4 2020.

  • Private Advisor Group reported no remaining Niagen Bioscience position as of Q4 2020 after selling out during the quarter.
  • Private Advisor Group sold 29,934 Niagen Bioscience shares in Q4 2020, an estimated $120K.
  • Private Advisor Group first reported a position in Niagen Bioscience in Q1 2018 and held it in 10 quarters.
  • Private Advisor Group's Niagen Bioscience position peaked at $137K in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2020.

Based on Private Advisor Group's 13F filing for Q4 2020, filed 1 Apr 2021.